Capstone Investment Advisors’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,741
Closed -$405K 1148
2024
Q1
$405K Sell
19,741
-3,148
-14% -$64.6K ﹤0.01% 908
2023
Q4
$491K Sell
22,889
-14,678
-39% -$315K ﹤0.01% 519
2023
Q3
$775K Buy
+37,567
New +$775K ﹤0.01% 448